According to Condor et al., Wharton’s Jelly-derived MSCs could decrease NF-κB levels and increase Klotho expression compared to the adipose-derived MSC (AD-MSCs) during cell therapy against sepsis-induced AKI [166]. The gene discussed is KL; the disease is acute kidney injury.